scholarly article | Q13442814 |
P2093 | author name string | Takaharu Ichimura | |
Xiaofei Li | |||
John Y Choi | |||
Leonardo V Riella | |||
Philip Chu | |||
Simiao Xu | |||
Thiago J Borges | |||
Ji Miao | |||
Jamil R Azzi | |||
Anil K Chandraker | |||
Peter T Sage | |||
Hengcheng Zhang | |||
Hazim Allos | |||
Juliano B Alhaddad | |||
Karim Yatim | |||
Saif A Muhsin | |||
Siawosh K Eskandari | |||
Songjie Cai | |||
P2860 | cites work | Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials | Q21131223 |
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice | Q24313409 | ||
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man | Q26776126 | ||
PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen | Q28305358 | ||
Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 | ||
The role of myeloid cells in the promotion of tumour angiogenesis | Q29614299 | ||
Monocyte recruitment during infection and inflammation | Q29620067 | ||
iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells. | Q33659263 | ||
Transforming growth factor beta (TGF-beta) and inflammation in cancer | Q33712568 | ||
Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling | Q33772651 | ||
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates | Q33804736 | ||
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice | Q33968062 | ||
Nomenclature of monocytes and dendritic cells in blood. | Q34125860 | ||
PD-1 on dendritic cells impedes innate immunity against bacterial infection | Q34606110 | ||
The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation | Q34846497 | ||
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer | Q35032491 | ||
Myeloid-derived suppressor cells prevent type 1 diabetes in murine models | Q35166486 | ||
The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 | ||
Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance | Q36084033 | ||
OPTN/SRTR 2017 Annual Data Report: Pancreas | Q91967809 | ||
OPTN/SRTR 2017 Annual Data Report: Lung | Q91967816 | ||
OPTN/SRTR 2017 Annual Data Report: Kidney | Q91967826 | ||
OPTN/SRTR 2017 Annual Data Report: Heart | Q91967830 | ||
Regulatory dendritic cells for human organ transplantation | Q92303151 | ||
Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. | Q36410807 | ||
TIM-3 regulates innate immune cells to induce fetomaternal tolerance. | Q36487481 | ||
PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity | Q36821174 | ||
Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 | ||
Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease | Q36880118 | ||
PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells | Q36986702 | ||
Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection | Q37628848 | ||
The nature of activatory and tolerogenic dendritic cell-derived signal II. | Q38085577 | ||
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig | Q38363193 | ||
Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy | Q38624477 | ||
Regulatory B Cells with a Partial Defect in CD40 Signaling and Overexpressing Granzyme B Transfer Allograft Tolerance in Rodents. | Q38957186 | ||
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus. | Q40255445 | ||
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. | Q40402774 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. | Q40758963 | ||
Prolonged Mouse Cardiac Graft Cold Storage via Attenuating Ischemia-Reperfusion Injury Using a New Antioxidant-Based Preservation Solution | Q40805746 | ||
Neonatal lymph node stromal cells drive myelodendritic lineage cells into a distinct population of CX3CR1+CD11b+F4/80+ regulatory macrophages in mice | Q43925027 | ||
Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis | Q44977673 | ||
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection | Q45375386 | ||
Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients | Q45813459 | ||
Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection. | Q46633572 | ||
p16Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis. | Q47113842 | ||
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function | Q47143373 | ||
Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy. | Q47706581 | ||
Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies | Q50177437 | ||
CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. | Q50893610 | ||
Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells. | Q50993283 | ||
Post-transplant surveillance for acute rejection and allograft vasculopathy by echocardiography: Usefulness of myocardial velocity and deformation imaging. | Q51051318 | ||
Distinct functions of CXCR4, CCR2, and CX3CR1 direct dendritic cell precursors from the bone marrow to the lung. | Q51157830 | ||
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. | Q51638237 | ||
Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. | Q53087524 | ||
βig-h3 Represses T-Cell Activation in Type 1 Diabetes. | Q53315716 | ||
Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. | Q54249272 | ||
Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation | Q58789294 | ||
Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival | Q73045866 | ||
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice | Q81332054 | ||
CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy | Q81817440 | ||
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease | Q83160725 | ||
Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells | Q83314647 | ||
Visualizing the Rapid and Dynamic Elimination of Allogeneic T Cells in Secondary Lymphoid Organs | Q89170057 | ||
High tacrolimus trough level variability is associated with rejections after heart transplant | Q89494276 | ||
IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development | Q90346463 | ||
OPTN/SRTR 2017 Annual Data Report: Intestine | Q91967777 | ||
OPTN/SRTR 2017 Annual Data Report: Liver | Q91967800 | ||
P433 | issue | 1 | |
P304 | page(s) | 14249 | |
P577 | publication date | 2020-08-28 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo | |
P478 | volume | 10 |
Search more.